There’s a lower threat of mild very low blood sugar (hypoglycemia) episodes if you take a GLP-1 agonist. It can become a significant threat if you are taking GLP-1s with other medications that lessen blood sugar, like sulfonylureas or insulin.Compounders must now pull their products. The grace time period for tirzepatide producers is more than, a